A topical small molecule drug candidate designed to treat radiation-induced maculopathy and other severe ocular diseases by blocking resistant angiogenesis, oxidative stress, inflammation, and fibrosis.

An oral small molecule drug candidate designed to treat metastatic uveal melanoma and other aggressive cancers by targeting angiogenic, fibrotic, and M2 macrophage-driven resistance mechanisms.